Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...

Hansa Biopharma AB, (Hansa) announced positive results from a 12-month follow up analysis from the NICE-01 trial of HNSA-5487, the company’s next generation immunoglobulin G (IgG)-cleaving molecule, ...